Oragenics, Inc.
Alachua, FL · CIK 0001174940 · Biotech · Public
Mutacin 1140 (MU1140), a lantibiotic novel antibiotic molecule engineered for Gram-positive infections
oragenics.com →- Grants
- $257K
- 1 award
- Sector median: 1
- Raised
- $67M
- 13 Form D · Aug 2023
- 38 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 0 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20092011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $11,237,011 | |
| Private capital raised | Form D · SEC | $5,798,001 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $2,538,185 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $13,000,000 | |
| Private capital raised | Form D · SEC | $9,900,000 | |
| Private capital raised | Form D · SEC | $4,666,666 | |
| Private capital raised | Form D · SEC | $1,302,292 | |
| Private capital raised | Form D · SEC | $6,676,209 | |
| Private capital raised | Form D · SEC | $1,800,000 | |
| Private capital raised | Form D · SEC | $4,600,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Computer-aided design for improved lantibiotics | $256,654 | |
| Private capital raised | Form D · SEC | $850,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2214 | BE COOL PHARMACEUTICS, LLC | — | — |
| 2215 | Xeris Pharmaceuticals, Inc. | — | $80M |
| 2216 | Avenzo Therapeutics | — | $79M |
| 2217 | Oragenics, Inc. | — | $67M |
| 2218 | Discidium Biosciences, LLC | — | — |
| 2219 | KINETIQ THERAPEUTICS LLC | — | — |
| 2220 | Immuneering Corp | — | $77M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brian BohunickyExecutive Officer
- JOHN BONFIGLIODirector · Executive Officer
- Alan DuntonDirector
- ALAN DUNTONDirector
- Jeffrey HillmanDirector · Executive Officer
- David HirschDirector · Executive Officer
- Janet HuffmanExecutive Officer
- Alan JoslynDirector · Executive Officer
- Robert KoskiDirector
- Christine KoskiDirector
- ROBERT KOSKIDirector
- CHRISTINE KOSKIDirector
- Kimberly MurphyDirector · Executive Officer
- Charles PopeDirector
- CHARLES POPEDirector
- Michael SullivanExecutive Officer
- MICHAEL SULLIVANExecutive Officer
- Frederick TellingDirector
- FREDERICK TELLINGDirector
Patents
- C-20 Steroid Compounds, Compositions And Uses Thereof To Treat Traumatic Brain Injury (tbi), Including Concussionsapplication
- Breath-powered Nasal Devices For Treatment Of Traumatic Brain Injury (tbi), Including Concussion, And Methodsapplication
- -ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-application
- C-20 Steroid Compounds, Compositions And Uses Thereof To Treat Traumatic Brain Injury (tbi), Including Concussionsapplication
- Differentially Protected Orthogonal Lanthionine Technologyapplication
- Methods For Treating Lipomas And Liposarcomasapplication
- Compositions For The Detection And Treatment Of Colorectal Cancerapplication
- Use Of Hydrogen Peroxide-producing Bacteria For Tooth Whiteningapplication
- In Vivo Induced Genes Of Mycobacterium Tuberculosisapplication
- Differentially Protected Orthogonal Lanthionine Technologyapplication
- Methods For Regulating Weight And Size Of Animalsapplication
- Compositions And Methods For The Maintenance Of Oral Healthapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.